0

Global Gene Therapy for CNS Disorders Market 2019-2023

  • Published: Mar 2019
  • Pages: 119
  • SKU: IRTNTR31112
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global gene therapy for CNS disorders market size will grow by USD 4.01 billion during 2019-2023. This report offers an analysis of the market based on indication (SMA and others). The gene therapy for CNS disorders market research report further presents in-depth insights on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Biogen, bluebird bio, Inc., Novartis AG, Pfizer Inc., and Voyager Therapeutics.

Below are some of the key findings from the gene therapy for CNS disorders market analysis report:

Gene Therapy for CNS Disorders Market

 

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!  

Global gene therapy for CNS disorders industry overview

Vendors are obtaining quicker approval for their novel gene therapies for CNS disorders with the help of special drug designations that are offered by various regulatory bodies. Special drug designations comprise of incentives such as fast track approval and tax credits and benefits released for new clinical research, providing economic relief to vendors. The continuous approval of gene therapy programs for CNS disorders will boost the adoption of gene therapy in various healthcare units.

Gene therapy for the treatment of CNS indications exhibits superior efficacy. This is attracting vendors to develop regenerative therapies and conduct studies for these indications. The substantial unmet need in the market for treating disorders such as Parkinson's disease is further encouraging vendors to conduct studies. This has led to a pipeline with multiple gene therapies for Parkinson's disease, various CNS indications, and multiple special drug designations. The presence of strong pipeline will support the quick approval of gene therapies for CNS disorders.  Such factors will drive gene therapy for CNS disorders market growth at a CAGR of almost 27% during the forecast period.

Top gene therapy for CNS disorders companies covered in this market research report

The gene therapy for CNS disorders market is highly concentrated. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by companies, this gene therapy for CNS disorders industry analysis report will help clients identify new growth opportunities and design effective strategies to improve their market share.

The report offers a complete analysis of various companies including:

  • Biogen
  • bluebird bio, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Voyager Therapeutics

Gene therapy for CNS disorders market segmentation based on geographic regions

  • Asia
  • Europe
  • North America
  • ROW

North America will account for the largest gene therapy for CNS disorders market share throughout the forecast period. The increasing number of novel gene therapies being developed for various CNS disorders is one of the major reasons for the high growth of the gene therapy for CNS disorders market in this region.

Gene therapy for CNS disorders market segmentation based on indication

  • SMA
  • Others

The SMA segment will account for the highest gene therapy for CNS disorders market share in 2018. Because of factors such as the high prevalence of SMA across all genders and races and the availability of therapy with superior efficacy, the segment will continue to dominate the market throughout the forecast period.

Key highlights of the global gene therapy for CNS disorders market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the gene therapy for CNS disorders market during the next five years
  • Precise estimation of the global gene therapy for CNS disorders market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the gene therapy for CNS disorders industry across various geographies such as Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of gene therapy for CNS disorders companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY INDICATION

  • Market segmentation by indication
  • Comparison by indication
  • SMA - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by indication

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Biogen
  • bluebird bio, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Voyager Therapeutics

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

PART 16: EXPLORE TECHNAVIO

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>